NCT06069180View on ClinicalTrials.gov

The Optimization of Conditioning Regimen for HLA Matched HSCT in SAA

PHASE4RecruitingINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

November 15, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions
Severe Aplastic Anemia
Interventions
DRUG

Busulfan

Conditioning regimens were Bu/Flu/Cy/ATG or Bu/Cy/ATG, depending on the patient's risk factors of regimen related cardiotoxicity.

DRUG

Flu/Cy/ATG or Cy/ATG

Conditioning regimens were Flu/Cy/ATG or Cy/ATG, depending on the patient's risk factors of regimen related cardiotoxicity.

Trial Locations (1)

100044

RECRUITING

Deparment of Hematology, Peking University People's Hospital, Beijing

All Listed Sponsors
lead

Peking University People's Hospital

OTHER